 Biogen stock surged Wednesday after partner Eisai unveiled Alzheimers treatment test results that two doctors reportedly described as magnificent. The post Why This New Alzheimers Update Is Likely To Spark A Debate For Biogen Investors appeared first on Investors Business Daily. 